Cancer treatments used to provide wide-ranging effects, but cabozantinib tablets deliver precise targeting by blocking specific tyrosine kinases that tumors need to grow. The drug restores treatment effectiveness by blocking MET and AXL pathways, which typically lead to treatment failure. The UK market approves cabozantinib tablets for use in radioiodine-refractory thyroid cancer and ... https://www.oddwayinternational.com/cabozantinib-tablet/